Internet-based acceptance and commitment therapy (iACT) improves professional psychological help-seeking attitudes: A randomized controlled trial.

J Affect DisordJul 28, 2026 (epub)
Clinical ResearchPsychiatry

Wenke Chen, Yunxiao Guo, Qian Xiong et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the effectiveness of Internet-based Acceptance and Commitment Therapy (iACT) in improving professional help-seeking attitudes among 91 male participants (Mean Age = 21.09). The iACT group demonstrated significantly greater improvements in help-seeking attitudes compared to the control group (F (3,87) = 5.95, p < 0.001), indicating the potential of iACT in addressing mental health stigma.

Key findings

  • The iACT group showed greater improvements in help-seeking attitudes than controls (F (3,87) = 5.95, p < 0.001).
  • Medium-to-large effects were observed for reducing psychological rigidity (d = -0.77) and self-stigma (d = -0.88) post-intervention.
  • Psychological rigidity reduction mediated the improvement in help-seeking attitudes (β = 0.47, SE = 0.08).

Why it matters

Improving help-seeking attitudes is essential for addressing mental health issues. This study highlights how internet-based interventions can effectively reduce stigma and enhance willingness to seek professional help.

Source

PubMed · PMID 42521092

Published in J Affect Disord. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.